Its expression levels and genetic variations can influence cancer risk, progression, and response to therapy, underscoring the importance of SOD3 in cancer biology, and its suppression in Asian PTC patients may contribute to heightened susceptibility by deregulating key oncogenic pathways. This evidence concerns the gene SOD3 and cancer.